Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Zhongji Innolight   / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/zhongji-innolight-co-ltd" target="_blank" data-smartkarma-citation="entities:6986:1" rel="noopener">Zhongji Innolight (300308 CH)</a> one of the world’s largest optical transceiver manufacturers, now aims to raise around US$7bn in its H-share listing.</li>
<li>Innolight was the global leader in 2025 in optical modules, with its products being in high demand for data centers.</li>
<li>In our previous notes, we have looked at the company’s past performance and recent filings updates. In this note, we talk about the likely A/H premium/discount.</li>
</ul>



Zhongji Innolight (300308 CH) one of the world’s largest optical transceiver manufacturers, now aims to raise around US$7bn in its H-share listing.
Innolight was the global leader in 2025 in optical modules, with its products being in high demand for data centers.
In our previous notes, we have looked at the company’s past performance and recent filings updates. In this note, we talk about the likely A/H premium/discount.


Aequitas: Innolight A/H Listing - Updated Peer Comp and Thoughts on Valuations

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

<ul>
<li>Zhongji Innolight, a global optical interconnect player, passed hearing for an A+H listing. GS, CICC, MS, and GF are the joint sponsors.</li>
<li>We look at the company's core segments: high-speed and mid-to-low-speed optical transceivers.</li>
<li>We discussed our preliminary thoughts on the company's valuation based on A-H premium.</li>
</ul>


Zhongji Innolight, a global optical interconnect player, passed hearing for an A+H listing. GS, CICC, MS, and GF are the joint sponsors.
We look at the company's core segments: high-speed and mid-to-low-speed optical transceivers.
We discussed our preliminary thoughts on the company's valuation based on A-H premium.


Zhongji Innolight (中际旭创) A+H Pre-IPO: Early Thoughts

<ul>
<li>
<a href="https://www.smartkarma.com/entities/zhongji-innolight-co-ltd" target="_blank" data-smartkarma-citation="entities:6986:1" rel="noopener">Zhongji Innolight (300308 CH)</a> one of the world’s largest optical transceiver manufacturers, now aims to raise around US$7bn in its H-share listing.</li>
<li>Innolight was the global leader in 2025 in optical modules, with its products being in high demand for data centers.</li>
<li>In our previous notes, we have looked at the company’s past performance and likely A/H premium/discount. In this note, we talk about the updates from its recent filing.</li>
</ul>



Zhongji Innolight (300308 CH) one of the world’s largest optical transceiver manufacturers, now aims to raise around US$7bn in its H-share listing.
Innolight was the global leader in 2025 in optical modules, with its products being in high demand for data centers.
In our previous notes, we have looked at the company’s past performance and likely A/H premium/discount. In this note, we talk about the updates from its recent filing.


Aequitas: Innolight A/H Listing - Filing Updates - Dominant Status, Strong Earnings

<ul>
<li>Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.</li>
<li>On the IPO front, a number of large listings are already gearing up for what is seeming to be a busy second half</li>
<li>There weren't many placements across but we did have a look at Archion's valuations in its indicative price range.</li>
</ul>


Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
On the IPO front, a number of large listings are already gearing up for what is seeming to be a busy second half
There weren't many placements across but we did have a look at Archion's valuations in its indicative price range.


Aequitas ECM Weekly (20 July 2026)- Innolight, Gcash, SBI, Jio, Tier IV, Robotechnik, Archion

HK/China Equity Long-Short

Osbert Tang, CFA

<ul>
<li>ChiNext-Listed <a href="https://www.smartkarma.com/entities/zhongji-innolight-co-ltd" target="_blank" data-smartkarma-citation="entities:6986:1" rel="noopener">Zhongji InnoLight (300308 CH)</a> is seeking an H-share IPO in Hong Kong, with the market expecting it to raise US$7-8bn. It is trading at 36.4x FY26 PER.<a href="mailto:FY@^" target="_blank" rel="noopener"></a>
</li>
<li>Key positives are its industry leadership with first-mover advantage, position to gain from AI infrastructure spending, and strategic R&amp;D investment and technological strengths.</li>
<li>Key negatives are its very high customer concentration, significant geopolitical and US market exposure, and product and technology transition risks.</li>
</ul>


ChiNext-Listed Zhongji InnoLight (300308 CH) is seeking an H-share IPO in Hong Kong, with the market expecting it to raise US$7-8bn. It is trading at 36.4x FY26 PER.

Key positives are its industry leadership with first-mover advantage, position to gain from AI infrastructure spending, and strategic R&amp;D investment and technological strengths.
Key negatives are its very high customer concentration, significant geopolitical and US market exposure, and product and technology transition risks.


Zhongji InnoLight (中际旭创) Pre-IPO: Key Positives and Negatives

China

Zhongji Innolight Co., Ltd. manufactures and distributes industrial machines and machine parts. The Company produces motor stator windings, insulating machines, coil winding equipment, automatic production lines, and more. Zhongji Innolight mainly conducts businesses domestically.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Zhongji Innolight (300308 CH)

Aequitas: Innolight A/H Listing - Updated Peer Comp and Thoughts on Valuations

Zhongji Innolight (300308 CH) one of the world’s largest optical transceiver manufacturers, now aims to raise around US$7bn in its H-share listing....

Sumeet Singh

Zhongji Innolight (中际旭创) A+H Pre-IPO: Early Thoughts

Zhongji Innolight passed hearing for an A+H listing. In this note, we look at the company's business, its industry context and provide our early...

Ke Yan, CFA, FRM

Aequitas: Innolight A/H Listing - Filing Updates - Dominant Status, Strong Earnings

Zhongji Innolight (300308 CH) the world’s largest optical transceiver manufacturers, now aims to raise around US$7bn in its H-share listing. In...

Sumeet Singh

Aequitas ECM Weekly (20 July 2026)- Innolight, Gcash, SBI, Jio, Tier IV, Robotechnik, Archion

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Sumeet Singh

Zhongji InnoLight (中际旭创) Pre-IPO: Key Positives and Negatives

Zhongji Innolight is seeking an H-share IPO in Hong Kong, expected to raise US$7-8bn. Trading at 36.4x FY26 PER, it has industry leadership and...

Osbert Tang, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Aequitas: Innolight A/H Listing - Updated Peer Comp and Thoughts on Valuations

Zhongji Innolight (300308 CH) one of the world’s largest optical transceiver manufacturers, now aims to raise around US$7bn in its H-share listing....

Sumeet Singh

Zhongji Innolight (中际旭创) A+H Pre-IPO: Early Thoughts

Zhongji Innolight passed hearing for an A+H listing. In this note, we look at the company's business, its industry context and provide our early...

Ke Yan, CFA, FRM

Aequitas: Innolight A/H Listing - Filing Updates - Dominant Status, Strong Earnings

Zhongji Innolight (300308 CH) the world’s largest optical transceiver manufacturers, now aims to raise around US$7bn in its H-share listing. In...

Sumeet Singh

Aequitas ECM Weekly (20 July 2026)- Innolight, Gcash, SBI, Jio, Tier IV, Robotechnik, Archion

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Sumeet Singh

Zhongji InnoLight (中际旭创) Pre-IPO: Key Positives and Negatives

​Zhongji Innolight is seeking an H-share IPO in Hong Kong, expected to raise US$7-8bn. Trading at 36.4x FY26 PER, it has industry leadership and...

Osbert Tang, CFA

Zhongji Innolight is seeking an H-share IPO in Hong Kong, expected to raise US$7-8bn. Trading at 36.4x FY26 PER, it has industry leadership and...